![](/img/cover-not-exists.png)
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
Anstensrud, Anne Kristine, Woxholt, Sindre, Sharma, Kapil, Broch, Kaspar, Bendz, Bjørn, Aakhus, Svend, Ueland, Thor, Amundsen, Brage H, Damås, Jan Kristian, Hopp, Einar, Kleveland, Ola, Stensæth, KVolume:
6
Journal:
Open Heart
DOI:
10.1136/openhrt-2019-001108
Date:
October, 2019
File:
PDF, 1.06 MB
2019